Sipuleucel-T and Androgen Receptor-Directed Therapy for Castration-Resistant Prostate Cancer: A Meta-Analysis

New treatments, such as sipuleucel-T and androgen receptor- (AR-) directed therapies (enzalutamide (Enz) and abiraterone acetate (AA)), have emerged and been approved for the management of castration-resistant prostate cancer (CRPC). There are still debates over their efficacy and clinical benefits....

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:J Immunol Res
Autores principales: Yi, Renliang, Chen, Baoxin, Duan, Peng, Zheng, Chanjiao, Shen, Huanyu, Liu, Qun, Yuan, Chen, Ou, Weilin, Zhou, Zhiheng
Formato: Artigo
Lenguaje:Inglês
Publicado: Hindawi Publishing Corporation 2016
Materias:
Review Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5183769/
https://ncbi.nlm.nih.gov/pubmed/28058266
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2016/4543861
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares